Name | Type | Posted | Actions |
|---|---|---|---|
75F40126Q133903_shear flow instrument.pdf | Jun 9, 2026 |
FDA shear flow instrument system
The Food and Drug Administration is seeking quotes for a shear flow instrument system for the Laboratory of Cellular Hematology. This combined synopsis and solicitation is for a system that mimics in vivo conditions to study human platelets and red blood cells. The procurement is a total small business set-aside under NAICS 334516. The agency specifies the BioFlux 200+ or an equivalent system meeting 13 technical requirements. Delivery is to Silver Spring, Maryland, and selection will use the Lowest Price Technically Acceptable process. Quotes are due June 16, 2026, and must not contain macros. The instrument must satisfy 13 minimum technical requirements to be considered acceptable for hematological research. The Laboratory of Cellular Hematology requires a system to evaluate human platelets and red blood cells by mimicking in vivo conditions.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.
Contact and place of performance
Tim Walbert
USA
This FDA requirement is for a shear flow instrument system designed to mimic in vivo conditions to evaluate human platelets and red blood cells in their physiological environment. Please see the attached PDF file titled: FDA 75F40126Q133903.